載入...
Nonglycemic effects of dipeptidyl peptidase-4 inhibitors
The review considers the major nonglycemic effects of dipeptidyl peptidase-4 inhibitors commonly used in diabetological practice, by using as an example sitagliptin, the first and most investigated representative of this class.
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Russo |
| 出版: |
"Consilium Medicum" Publishing house
2013-01-01
|
| 叢編: | Терапевтический архив |
| 主題: | |
| 在線閱讀: | https://ter-arkhiv.ru/0040-3660/article/view/31226 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|